112 related articles for article (PubMed ID: 21094167)
1. Stabilizing the eIF4G1 α-helix increases its binding affinity with eIF4E: implications for peptidomimetic design strategies.
Brown CJ; Lim JJ; Leonard T; Lim HC; Chia CS; Verma CS; Lane DP
J Mol Biol; 2011 Jan; 405(3):736-53. PubMed ID: 21094167
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ovarian cancer growth by a tumor-targeting peptide that binds eukaryotic translation initiation factor 4E.
Ko SY; Guo H; Barengo N; Naora H
Clin Cancer Res; 2009 Jul; 15(13):4336-47. PubMed ID: 19458052
[TBL] [Abstract][Full Text] [Related]
3. Repressor binding to a dorsal regulatory site traps human eIF4E in a high cap-affinity state.
Ptushkina M; von der Haar T; Karim MM; Hughes JM; McCarthy JE
EMBO J; 1999 Jul; 18(14):4068-75. PubMed ID: 10406811
[TBL] [Abstract][Full Text] [Related]
4. Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells.
Goldson TM; Vielhauer G; Staub E; Miller S; Shim H; Hagedorn CH
Mol Carcinog; 2007 Jan; 46(1):71-84. PubMed ID: 17091471
[TBL] [Abstract][Full Text] [Related]
5. After fertilization of sea urchin eggs, eIF4G is post-translationally modified and associated with the cap-binding protein eIF4E.
Oulhen N; Salaün P; Cosson B; Cormier P; Morales J
J Cell Sci; 2007 Feb; 120(Pt 3):425-34. PubMed ID: 17213333
[TBL] [Abstract][Full Text] [Related]
6. Identification and function of the second eIF4E-binding region in N-terminal domain of eIF4G: comparison with eIF4E-binding protein.
Umenaga Y; Paku KS; In Y; Ishida T; Tomoo K
Biochem Biophys Res Commun; 2011 Oct; 414(3):462-7. PubMed ID: 21964297
[TBL] [Abstract][Full Text] [Related]
7. Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins.
Niedzwiecka A; Marcotrigiano J; Stepinski J; Jankowska-Anyszka M; Wyslouch-Cieszynska A; Dadlez M; Gingras AC; Mak P; Darzynkiewicz E; Sonenberg N; Burley SK; Stolarski R
J Mol Biol; 2002 Jun; 319(3):615-35. PubMed ID: 12054859
[TBL] [Abstract][Full Text] [Related]
8. A mutant of eukaryotic protein synthesis initiation factor eIF4E(K119A) has an increased binding affinity for both m7G cap analogues and eIF4G peptides.
Friedland DE; Wooten WN; LaVoy JE; Hagedorn CH; Goss DJ
Biochemistry; 2005 Mar; 44(11):4546-50. PubMed ID: 15766285
[TBL] [Abstract][Full Text] [Related]
9. Dynamic Interaction of Eukaryotic Initiation Factor 4G1 (eIF4G1) with eIF4E and eIF1 Underlies Scanning-Dependent and -Independent Translation.
Haimov O; Sehrawat U; Tamarkin-Ben Harush A; Bahat A; Uzonyi A; Will A; Hiraishi H; Asano K; Dikstein R
Mol Cell Biol; 2018 Sep; 38(18):. PubMed ID: 29987188
[TBL] [Abstract][Full Text] [Related]
10. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
[TBL] [Abstract][Full Text] [Related]
11. Improved eIF4E binding peptides by phage display guided design: plasticity of interacting surfaces yield collective effects.
Zhou W; Quah ST; Verma CS; Liu Y; Lane DP; Brown CJ
PLoS One; 2012; 7(10):e47235. PubMed ID: 23094039
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1.
Tan A; Bitterman P; Sonenberg N; Peterson M; Polunovsky V
Oncogene; 2000 Mar; 19(11):1437-47. PubMed ID: 10723135
[TBL] [Abstract][Full Text] [Related]
13. Structures of the human eIF4E homologous protein, h4EHP, in its m7GTP-bound and unliganded forms.
Rosettani P; Knapp S; Vismara MG; Rusconi L; Cameron AD
J Mol Biol; 2007 May; 368(3):691-705. PubMed ID: 17368478
[TBL] [Abstract][Full Text] [Related]
14. Potyvirus terminal protein VPg, effector of host eukaryotic initiation factor eIF4E.
Grzela R; Strokovska L; Andrieu JP; Dublet B; Zagorski W; Chroboczek J
Biochimie; 2006 Jul; 88(7):887-96. PubMed ID: 16626853
[TBL] [Abstract][Full Text] [Related]
15. A new translational regulator with homology to eukaryotic translation initiation factor 4G.
Imataka H; Olsen HS; Sonenberg N
EMBO J; 1997 Feb; 16(4):817-25. PubMed ID: 9049310
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
17. Consideration of Binding Kinetics in the Design of Stapled Peptide Mimics of the Disordered Proteins Eukaryotic Translation Initiation Factor 4E-Binding Protein 1 and Eukaryotic Translation Initiation Factor 4G.
Gallagher EE; Song JM; Menon A; Mishra LD; Chmiel AF; Garner AL
J Med Chem; 2019 May; 62(10):4967-4978. PubMed ID: 31033289
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of protein synthesis in apoptosis: differential requirements by the tumor necrosis factor alpha family and a DNA-damaging agent for caspases and the double-stranded RNA-dependent protein kinase.
Jeffrey IW; Bushell M; Tilleray VJ; Morley S; Clemens MJ
Cancer Res; 2002 Apr; 62(8):2272-80. PubMed ID: 11956083
[TBL] [Abstract][Full Text] [Related]
20. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G.
Moerke NJ; Aktas H; Chen H; Cantel S; Reibarkh MY; Fahmy A; Gross JD; Degterev A; Yuan J; Chorev M; Halperin JA; Wagner G
Cell; 2007 Jan; 128(2):257-67. PubMed ID: 17254965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
